Do not share your Saxenda® pen with others even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Significant demand for weight-management medicines has impacted the availability of Novo Nordisk obesity medications, including Saxenda®. We continue to produce and ship all available Saxenda®, but unfortunately, you may still have difficulty filling Saxenda® prescriptions for the remainder of 2023 and beyond. We continue to assess demand and look for ways to best plan for the future. We sincerely regret and apologize for any disruptions in care that you may experience. We encourage you to discuss alternative treatment options with your health care provider and to work together to adjust your care plan appropriately. For additional questions, please call the Saxenda® Hotline, 1‑844‑845‑6913, Monday through Friday, 8:30 am to 6:00 pm ET.
You’ve come to the right place to find coverage and cost information.
You’ve come to the right place to find coverage and cost information.
Complete a quick form to find out your coverage and cost in minutes.
The Saxenda® Saving Offer program has been discontinued for new enrollees as of June 30, 2023. If you have a Saxenda® Savings Offer that you activated and redeemed on or before June 30, 2023, you can take advantage of its benefits until December 31, 2023, without additional action required.
Eligibility and other restrictions apply. Novo Nordisk reserves the right to modify or cancel this program at any time.
If you need help affording your prescription, the makers of Saxenda® have another weight-management option with a savings offer. Ask your health care provider if this option is right for you.
It’s important to properly dispose of your used Novo Nordisk products.